Characteristics of tumor infiltration by adoptively transferred and endogenous natural-killer cells in a syngeneic rat model: Implications for the mechanism behind anti-tumor responses

International Journal of Cancer

Volumn 78, Issue 6, 1998, Pages 783-789

  Hagenaars, M ^a   Zwaveling, S ^a   Kuppen, P J K ^a   Ensink, N G ^a   Eogermont, A M M ^b   Hokland, M E ^c   Basse, P H ^c   Van de Velde, C J H ^a   Fleuren, G J ^a   Nannmark, U ^c,d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL INTERACTION; ELECTRON MICROSCOPY; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR REGRESSION;

ADOPTIVE TRANSFER; ANIMALS; GRANULOCYTES; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2; KILLER CELLS, NATURAL; KINETICS; LIVER NEOPLASMS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICROSCOPY, ELECTRON; NEOPLASM TRANSPLANTATION; RATS; RATS, INBRED STRAINS; TUMOR CELLS, CULTURED;

EID: 0031795307     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19981209)78:6<783::AID-IJC17>3.0.CO;2-C     Document Type: Article

References (39)

1. BASSE, P.H., GOLDFARB, R.H., HERBERMAN, R.B. and HOKLAND, M.E., Accumulation of adoptively transferred A-NK cells in murine metastases: kinetics and role of interleukin-2. In Vivo, 8, 17-24 (1994).
2. BASSE, PH., HERBERMAN, R.B., HOKLAND. M. and GOLDFARB, R.H., Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels. Cancer ImmnnoL Immunother., 34, 221-227 (1992a).
3. BASSE, P.H., HERBERMAN, R.B., HOKLAND, M.E. and GOLDFARB, R.H., Tissue distribution of adoptively transferred adherent LAK cells: role of the route of administration. Nat. Immun., 11, 193-202 (1992b).
4. BASSE, PH., HERBERMAN, R.B., NANNMARK, U., JOHANSSON, B.R., HOKLAND, M., WASSERMAN, K. and GOLDFARB, R.H., Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases. J. exp, Med., 174, 479-488 (1991a).
5. BASSE, PH., NANNMARK, U., JOHANSSON, B.R., HERBERMAN, R.B. and GOLDFARB, R.H., Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells. J. nat. Cancer Inst., 83, 944-950 (1991b).
6. BEUN, G.D.M., VAN EENDENBURG, J.D.H., CORVER, W.E., VAN DE VELDE, C.J.H. and FLEUREN. G.J., T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged preactivation of effector T lymphocytes by immobilized anti-T-cell receptor antibody. J. Immunother:, 11, 238-248 (1992).
7. BOUWENS, L., MARINELLI, A., KUPPEN, P.J.K., EGGERMONT, A.M.M., VAN DE VELDE, CJ.H. and WISSE, E., Electron microscopic observations on the accumulation of large granular lymphocytes (pit cells) and Kupffer cells in the liver of rats treated with continuous infusion of interleukin-2. Hepatology, 12, 1365-1370 (1990).
8. CHAMBERS, W.H., VUJANOVIC, N.L., DELEO, A.B., OLSZOWY, M.W., HERBERMAN, R.B. and HISERODT, J.C., Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J.exp.Med., 169, 1373-1389 (1989).
9. GIEZEMAN-SMITS, K.M., GORTER, A., NAGELKERKE, J.F., VAN VLIERBERGHE, R.L.P., VAN EENDENBURG, J., EGGERMQNT, A.M.M., FLEUREN, G.J. and KUPPEN, P.J.K., Characterization of three new membrane structures on rat NK cells which are involved in activation of the lytic machinery. Immunobiology, 197, 429-443 (1997).
10. GOLDFARB, R.H., WASSERMAN, K., HERBERMAN, R.B. and KITSON, R.P., Non-granular proteolytic enzymes of rat IL-2-activated natural killer cells. I. Subcellular localization and functional role. J. Immunol, 149, 2061-2068 (1992).
11. HAGENAARS, M., ENSINK, N.G., KOELEMIJ, R., BASSE, PH., EGGERMONT, A.M.M., VAN DE VELDE, C.J.H., FLEUREN, G.J. and KUPPEN, P.J.K., Regional administration of natural killer cells in a rat hepatic metastasis model results in better tumor infiltration and anti-tumor response than systemic administration. Int. J. Cancer, 75, 233-238 (1998).
12. JOHANSSON, B.R. and NANNMARK, U., Ultrastructure of interactions between activated murine natural killer cells and melanoma cells in an extracellular matrix (MatrigeKR)} environment. Nat. Immun., 15, 98-106 (1996).
13. KITSON, R.P., MILLER, C.A. and GOLDFARB, R.H., Non-granular proteolytic enzymes of rat interteukin-2-activated natural killer cells. III. Enhancement of A-NKP 1, 2 and 3 proteolytic activities (cleaving after Arg, Phe and Pro) in response to imerleukin-2. Nat. Immun., 14, 286-294 (1995).
14. KOS, F.J. and ENGLEMAN, E.G., Requirement for natural-killer cells in the induction of cytotoxic T cells. J. Immunol, 155, 578-584 (1995).
15. KOS, F.J. and ENGLEMAN, E.G., Immune regulation: a critical link between NK cells and CTLs. Immunol. Today, 17, 174-176 (1996).
16. KUPPEN, P.J.K., BASSE, PH., GOLDFARB, R.H., VAN DE VELDE, C.J.H., FLEUREN, G.J. and EGGERMONT, A.M.M., The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin-2-activated natural killer cells in Wag rats. Int. J. Cancer, 56, 574-579 (1994).
17. KUPPEN, P.J.K., MARINELLI, A., CAMPS, J.A.J., PAUWELS, E.K.J., VAN DE VELDE, C.J.H., FLEUREN, G.J. and EGGERMONT, A.M.M., Biodistribution of lymphokine-activated killer (LAK) cells in Wag rats after hepatic-artery or jugular-vein infusion. Int. J. Cancer, 52, 266-270 (1992).
18. KUROSAWA, S., HARADA, M., MATSUZAKI, G., SHINOMIYA, Y. TERAO, H., KOBAYASHI, N. and NOMOTO, K., Early appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. Immunology 85, 338-346 (1995).
19. LAFRENIERE, R. and ROSENBRG, S.A., Adoptive immunotherapy of murine hepatic metastases with lymphokine activated killer (LAK) cells and recombinant interleukin 2 (RIL 2) can mediate the regression of both immunogenic and nonimmunogenic sarcomas and an adenocarcinoma. J. Immimol 135, 4273-4280 (1985b).
20. LAFRENIERE, R. and ROSENBERG, S.A., Successful immunotherapy of experimental hepatic metastases with lymphokine-activated killer cells and recombinant imerieukin-2. Cancer Res., 45, 3735-3741 (1985b).
21. LI, Y.Q., KOBAYASHI, M., KURAMITSU, Y., YUAN, L., MATSUSHITA, K., YAGITA. H-, OKUMURA, K. and HOSOKAWA, M., Enhancement of lymphokine-activated killer cell activity by fibronectin. J. Immunother., 20, 123-130 (1997).
22. MARQUET, R.L., WESTBROEK, D.L. and JEEKEL, J., Interferon treatment of a transplantable rat colon adenocarcinoma: importance of tumor site. Int. J. Cancer, 33, 689-692 (1984).
23. MARTIN, G.R. and TIMPL, R., Laminin and other basement membrane components. Ann. Rev. Cell. Biol, 3, 57-85 (1987).
24. MUSIANI, P., ALLIONE, A., MODICA, A., LOLLINI, P.L., GIOVARELLI, M., CAVALLO, F., BELARDELLI, F., FORNI, G. and MODESTI, A., Role of neutrophils and lymphocytes in inhibition of a mouse adenocarcinoma engineered to release IL-2, IL-4, 1L-7, IL-10, IFN-alpha, IFN-gamma and TNF-alpha. Lab. Invest., 74, 146-157 (1996).
25. NANNMARK, U., JOHANSSON, B.R., BRYANT, J.L., UNGER, M.L., HOKLAND, M.E., GOLDFARB, R.H. and BASSE, PH., Microvessel origin and distribution in pulmonary metastases of B16 melanoma: implication for adoptive immunotherapy. Cancer Res., 55, 4627-4632 (1995).
26. NANNMARK, U., KITSON, R.P., JOHANSSON, B.R., RIVETT, A.J. and GOLDFARB, R.H., Immunocytochemical localization of multicatalytic protease complex (proteasome) during generation of murine IL-2-activated natural killer (A-NK) cells. Europ. J. Cell Biol, 71, 402-408 (1996).
27. OKADA, K., NANNMARK, U., VUJANOVIC, N.L., WATKINS, S., BASSE, P., HERBERMAN, R.B. and WHITESIDE, T.L., Elimination of established liver metastases by human interleukin 2-activated natural killer cells after locoregional or systemic adoptive. Cancer Res., 56, 1599-1608 (1996).
28. RABINOWICH, H., VITOLO, D., ALTARAC, S., HERBERMAN, R.B. and WHITESIDE, T.L., Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. J. Immunol, 149, 340-349 (1992).
29. RATNER, S., PATRICK, P. and BORA, G., Lymphocyte development of adherence and motility in extracellular matrix during IL-2 stimulation. J. Immunol, 149, 681-688 (1992).
30. ROSENBERG, S.A. and 12 OTHERS, A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. New Engl. J. Med., 316, 889-897 (1987).
31. ROSENBERG, S.A., LOTZE, M.T., YANG, J.C., TOPALIAN, S.L., CHANG, A.E., SCHWARTZENTRUBER, D.J., AEBERSOLD. P., LEITMAN, S., LlNEHAN, W.M., SEIPP, C.A., WHITE, D.E. and STEINBERG, S.M., Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokineactivated killer ceils for the treatment of patients with advanced cancer. J. nat. Cancer Inst., 85, 622-632 (1993).
32. SASAKI, A., MELDER, R.J., WHITESIDE, T.L., HERBERMAN, R.B. and JAIN, R.K., Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation. J. nat. Cancer Inst., 83, 433-437 (1991).
33. SCHWARZ, R.E., VUJANOVIC, N.L. and HISERODT, J.C., Enhanced antimetastatic activity of lymphokine-activated killer cells purified and expanded by their adherence to plastic. Cancer Res., 49, 1441-1446 (1989).
34. SOMERSALO, K. and SAKSELA, E., Fibronectin facilitates the migration of human natural killer cells. Europ. J. Immunol, 21, 35-42 (1991).
35. THOMAS, C., NIJENHUIS, A.M., TIMENS, W., KUPPEN, P.J.K., DAEMEN, T. and SCHERPHOF, G.L., Liver metastasis model of colon cancer in the rat: immunohistochemical characterization. Invasion Metastasis, 13, 102-112 (1993).
36. UNGER, M.L., JOHANSSON, B.R. and NANNMARK, U., Migration of IL2 activated natural killer cells in vitro: influence of extracellular matrix proteins. APMIS, 104, 840-847 (1996).
37. VITOLO, D., VUJANOVIC, N.L., SCHLESINGER, M., HERBERMAN, R.B. and WHITESIDE, T.L., Rapid IL2 induced adherence of human natural killer cells: expression of mRNA for cytokines and IL2 receptors in adherent NK cells. J Immunol 151, 1926-1937 (1993).
38. WASSERMAN, K., KJTSON, R.P., GABAUER, M.K., MILLER, C.A., HERBERMAN, R.B. and GOLDFARB, R.H., Zymographic analysis of extracellular, released and cell-associated proteases of rat interleukin 2-activated natural killer (A-NK) cells. In Vivo, 8, 33-42 (1994).
39. XIA, M., LEPPERT, D., HAUSER, S.L., SREEDHARAN, S.P., NELSON, P.J., KRENSKY, A.M. and GOETZL, E.J., Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J. Immunol, 156, 160-167 (1996).